Novacyt (ALNOV) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.141x

Based on the latest financial reports, Novacyt (ALNOV) has a cash flow conversion efficiency ratio of -0.141x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.28 Million ≈ $-3.84 Million USD) by net assets (€23.34 Million ≈ $27.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALNOV company net worth for the company's overall valuation and market capitalisation.

Novacyt - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Novacyt's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Novacyt Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Novacyt ranked by their cash flow conversion efficiency. Explore ALNOV cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Zaklady Przemyslu Cukierniczego Otmuchow S.A. WAR:OTM	0.034x
IHQ Inc KO:003560	0.072x
Arribatec Solutions ASA OL:ARR	0.035x
Chi Hua Fitness Co Ltd TWO:1593	0.029x
WT Financial Group Ltd AU:WTL	0.125x
Corline Biomedical AB ST:CLBIO	0.001x
Chih Lien Industrial Co Ltd TW:2024	0.020x
Staatl. Mineralbrunnen AG MU:SLB	N/A

Annual Cash Flow Conversion Efficiency for Novacyt (2009–2025)

The table below shows the annual cash flow conversion efficiency of Novacyt from 2009 to 2025. View latest Novacyt stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€23.34 Million ≈ $27.29 Million	€-8.76 Million ≈ $-10.24 Million	-0.375x	-111.64%
2024-12-31	€47.88 Million ≈ $55.98 Million	€-8.49 Million ≈ $-9.93 Million	-0.177x	+38.10%
2023-12-31	€87.24 Million ≈ $102.00 Million	€-24.99 Million ≈ $-29.22 Million	-0.286x	-140.40%
2022-12-31	€115.22 Million ≈ $134.70 Million	€-13.73 Million ≈ $-16.05 Million	-0.119x	-207.71%
2021-12-31	€141.81 Million ≈ $165.80 Million	€15.69 Million ≈ $18.34 Million	0.111x	-83.81%
2020-12-31	€150.71 Million ≈ $176.20 Million	€102.98 Million ≈ $120.39 Million	0.683x	+1029.33%
2019-12-31	€12.47 Million ≈ $14.58 Million	€-916.70K ≈ $-1.07 Million	-0.074x	-18.83%
2018-12-31	€18.15 Million ≈ $21.22 Million	€-1.12 Million ≈ $-1.31 Million	-0.062x	+66.82%
2017-12-31	€22.12 Million ≈ $25.86 Million	€-4.12 Million ≈ $-4.82 Million	-0.186x	-29.43%
2016-12-31	€15.15 Million ≈ $17.71 Million	€-2.18 Million ≈ $-2.55 Million	-0.144x	+77.91%
2015-12-31	€6.05 Million ≈ $7.07 Million	€-3.95 Million ≈ $-4.61 Million	-0.652x	-1282.94%
2014-12-31	€14.40 Million ≈ $16.83 Million	€-678.92K ≈ $-793.73K	-0.047x	+92.08%
2013-12-31	€1.80 Million ≈ $2.10 Million	€-1.07 Million ≈ $-1.25 Million	-0.595x	-254.27%
2012-12-31	€1.34 Million ≈ $1.57 Million	€-225.28K ≈ $-263.37K	-0.168x	-121.72%
2011-12-31	€-744.73K ≈ $-870.67K	€-576.20K ≈ $-673.63K	0.774x	+2037.72%
2010-12-31	€-845.81K ≈ $-988.85K	€33.77K ≈ $39.48K	-0.040x	-103.70%
2009-12-31	€-654.03K ≈ $-764.63K	€-705.19K ≈ $-824.44K	1.078x	--

About Novacyt

PA:ALNOV France Medical Devices

Market Cap

$40.81 Million

€34.91 Million EUR

Market Cap Rank

#22828 Global

#353 in France

Share Price

€0.48

Change (1 day)

+0.10%

52-Week Range

€0.32 - €0.90

All Time High

€13.24